Literature DB >> 25099904

Cost of services provided by the National Breast and Cervical Cancer Early Detection Program.

Donatus U Ekwueme1, Sujha Subramanian, Justin G Trogdon, Jacqueline W Miller, Janet E Royalty, Chunyu Li, Gery P Guy, Wesley Crouse, Hope Thompson, James G Gardner.   

Abstract

BACKGROUND: The National Breast and Cervical Cancer Early Detection Program (NBCCEDP) is the largest cancer screening program for low-income women in the United States. This study updates previous estimates of the costs of delivering preventive cancer screening services in the NBCCEDP.
METHODS: We developed a standardized web-based cost-assessment tool to collect annual activity-based cost data on screening for breast and cervical cancer in the NBCCEDP. Data were collected from 63 of the 66 programs that received funding from the Centers for Disease Control and Prevention during the 2006/2007 fiscal year. We used these data to calculate costs of delivering preventive public health services in the program.
RESULTS: We estimated the total cost of all NBCCEDP services to be $296 (standard deviation [SD], $123) per woman served (including the estimated value of in-kind donations, which constituted approximately 15% of this total estimated cost). The estimated cost of screening and diagnostic services was $145 (SD, $38) per women served, which represented 57.7% of the total cost excluding the value of in-kind donations. Including the value of in-kind donations, the weighted mean cost of screening a woman for breast cancer was $110 with an office visit and $88 without, the weighted mean cost of a diagnostic procedure was $401, and the weighted mean cost per breast cancer detected was $35,480. For cervical cancer, the corresponding cost estimates were $61, $21, $415, and $18,995, respectively.
CONCLUSIONS: These NBCCEDP cost estimates may help policy makers in planning and implementing future costs for various potential changes to the program.
© 2014 American Cancer Society.

Entities:  

Keywords:  NBCCEDP; breast cancer screening; cervical cancer screening; cost analysis; economic cost; program evaluation

Mesh:

Year:  2014        PMID: 25099904      PMCID: PMC5822677          DOI: 10.1002/cncr.28816

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  34 in total

1.  Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys.

Authors:  N Breen; D K Wagener; M L Brown; W W Davis; R Ballard-Barbash
Journal:  J Natl Cancer Inst       Date:  2001-11-21       Impact factor: 13.506

Review 2.  Evaluation of cervical cytology.

Authors:  D C McCrory; D B Matchar; L Bastian; S Datta; V Hasselblad; J Hickey; E Myers; K Nanda
Journal:  Evid Rep Technol Assess (Summ)       Date:  1999-01

3.  Screening mammography: costs and use of screening-related services.

Authors:  Steven P Poplack; Patricia A Carney; Julia E Weiss; Linda Titus-Ernstoff; Martha E Goodrich; Anna N A Tosteson
Journal:  Radiology       Date:  2005-01       Impact factor: 11.105

Review 4.  A review of cervical cancer screening intervention research: implications for public health programs and future research.

Authors:  A C Marcus; L A Crane
Journal:  Prev Med       Date:  1998 Jan-Feb       Impact factor: 4.018

5.  Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness.

Authors:  John T Schousboe; Karla Kerlikowske; Andrew Loh; Steven R Cummings
Journal:  Ann Intern Med       Date:  2011-07-05       Impact factor: 25.391

Review 6.  Intervention to increase recommendation and delivery of screening for breast, cervical, and colorectal cancers by healthcare providers a systematic review of provider reminders.

Authors:  Roy C Baron; Stephanie Melillo; Barbara K Rimer; Ralph J Coates; Jon Kerner; Nancy Habarta; Sajal Chattopadhyay; Susan A Sabatino; Randy Elder; Kimberly Jackson Leeks
Journal:  Am J Prev Med       Date:  2010-01       Impact factor: 5.043

7.  Interventions that increase use of adult immunization and cancer screening services: a meta-analysis.

Authors:  Erin G Stone; Sally C Morton; Marlies E Hulscher; Margaret A Maglione; Elizabeth A Roth; Jeremy M Grimshaw; Brian S Mittman; Lisa V Rubenstein; Laurence Z Rubenstein; Paul G Shekelle
Journal:  Ann Intern Med       Date:  2002-05-07       Impact factor: 25.391

8.  Disparities in mammography use among US women aged 40-64 years, by race, ethnicity, income, and health insurance status, 1993 and 2005.

Authors:  Susan A Sabatino; Ralph J Coates; Robert J Uhler; Nancy Breen; Florence Tangka; Kate M Shaw
Journal:  Med Care       Date:  2008-07       Impact factor: 2.983

9.  Estimating personal costs incurred by a woman participating in mammography screening in the National Breast and Cervical Cancer Early Detection Program.

Authors:  Donatus U Ekwueme; Ingrid J Hall; Lisa C Richardson; James G Gardner; Janet Royalty; Trevor D Thompson
Journal:  Cancer       Date:  2008-08-01       Impact factor: 6.860

10.  Missed opportunities: racial disparities in adjuvant breast cancer treatment.

Authors:  Nina A Bickell; Jason J Wang; Soji Oluwole; Deborah Schrag; Henry Godfrey; Karen Hiotis; Jane Mendez; Amber A Guth
Journal:  J Clin Oncol       Date:  2006-03-20       Impact factor: 44.544

View more
  10 in total

1.  The Need for Societal Investment to Improve Cervical Cancer Outcomes in Nigeria: A commentary.

Authors:  Jonah Musa
Journal:  Afr J Reprod Health       Date:  2017-12

2.  Costs of colorectal cancer screening provision in CDC's Colorectal Cancer Control Program: Comparisons of colonoscopy and FOBT/FIT based screening.

Authors:  Sujha Subramanian; Florence K L Tangka; Sonja Hoover; Janet Royalty; Amy DeGroff; Djenaba Joseph
Journal:  Eval Program Plann       Date:  2017-02-07

3.  Awardee-specific economic costs of providing cancer screening and health promotional services to medically underserved women eligible in the National Breast and Cervical Cancer Early Detection Program.

Authors:  Sujha Subramanian; Donatus U Ekwueme; Jacqueline W Miller; Jaya S Khushalani; Justin G Trogdon; Faye L Wong
Journal:  Cancer Causes Control       Date:  2019-05-20       Impact factor: 2.506

4.  Reported breast symptoms in the National Breast and Cervical Cancer Early Detection Program.

Authors:  A Blythe Ryerson; Jacqueline Miller; Christie R Eheman
Journal:  Cancer Causes Control       Date:  2015-03-10       Impact factor: 2.506

5.  The effect of delivery structure on costs, screening and health promotional services in state level National Breast and Cervical Cancer Early Detection Programs.

Authors:  Justin G Trogdon; Donatus U Ekwueme; Sujha Subramanian; Jacqueline W Miller; Faye L Wong
Journal:  Cancer Causes Control       Date:  2019-06-11       Impact factor: 2.506

6.  Economics of public health programs for underserved populations: a review of economic analysis of the National Breast and Cervical Cancer Early Detection Program.

Authors:  Jaya S Khushalani; Justin G Trogdon; Donatus U Ekwueme; K Robin Yabroff
Journal:  Cancer Causes Control       Date:  2019-10-09       Impact factor: 2.506

7.  Cost-effectiveness of breast cancer screening in the National Breast and Cervical Cancer Early Detection Program.

Authors:  Sun Hee Rim; Benjamin T Allaire; Donatus U Ekwueme; Jacqueline W Miller; Sujha Subramanian; Ingrid J Hall; Thomas J Hoerger
Journal:  Cancer Causes Control       Date:  2019-05-16       Impact factor: 2.506

Review 8.  Population-based cancer screening programmes in low-income and middle-income countries: regional consultation of the International Cancer Screening Network in India.

Authors:  Sudha Sivaram; Gautam Majumdar; Douglas Perin; Ashrafun Nessa; Mireille Broeders; Elsebeth Lynge; Mona Saraiya; Nereo Segnan; Rengaswamy Sankaranarayanan; Preetha Rajaraman; Edward Trimble; Stephen Taplin; G K Rath; Ravi Mehrotra
Journal:  Lancet Oncol       Date:  2018-02       Impact factor: 41.316

9.  Preventing Breast, Cervical, and Colorectal Cancer Deaths: Assessing the Impact of Increased Screening.

Authors:  Krishna P Sharma; Scott D Grosse; Michael V Maciosek; Djenaba Joseph; Kakoli Roy; Lisa C Richardson; Harold Jaffe
Journal:  Prev Chronic Dis       Date:  2020-10-08       Impact factor: 2.830

10.  Can we increase efficiency of CT lung cancer screening by combining with CVD and COPD screening? Results of an early economic evaluation.

Authors:  Carina M Behr; Hendrik Koffijberg; Koen Degeling; Rozemarijn Vliegenthart; Maarten J IJzerman
Journal:  Eur Radiol       Date:  2022-01-01       Impact factor: 7.034

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.